The preferred neoadjuvant chemotherapy regimen is a platinum-taxane doublet. The American Society of Clinical Oncology (ASCO) has updated its guidelines on neoadjuvant chemotherapy use in patients ...

Underrepresentation of Asian Americans, Native Hawaiians, and other Pacific Islanders (AA & NHPI) in cancer clinical trials that led to FDA approvals in 2010-2022. This is an ASCO Meeting Abstract ...

Dr Robert Coleman, chief scientific officer of the US Oncology Network, reflects on the evolution of ovarian cancer treatment guidelines from early in his career to the dramatic shifts in the past few ...

SGO Many Ovarian Cancer Patients Don't Get Recommended Treatment Only 37% of patients with ovarian cancer are treated according to guidelines, even though adherence to guidelines improves survival.

Current CA-125 thresholds may miss ovarian cancer in racially diverse patients, delaying treatment initiation and contributing to health disparities. Original CA-125 studies were conducted on ...

The MarketWatch News Department was not involved in the creation of this content. A study led by Roswell Park provides new insight into the complex interactions of the "tumor-immune-gut axis," and its ...